Imago BioSciences
Latest round
- Series C
Last raised
- Nov 2020
Total raised
- $106M
Investors
- 18
About Imago BioSciences
Founded in 2012 and based in California, US, Imago BioSciences, Inc. operates as a biopharmaceutical company that develops various therapeutical solutions for the treatment of bone marrow diseases and hematologic disorders targeting epigenetic enzymes. The company was founded by its CEO Hugh Rienhoff. In November 2020, Imago BioSciences, Inc. The company released its IPO on NASDAQ in July 2015 under the ticker symbol IMGO. The company's product consists of therapeutical solutions that focus on the treatment of thrombocythemia, myelofibrosis, other myeloproliferative neoplasms, bone marrow diseases, and hematologic disorders. It offers Bomedemstat, an orally available LSD1 inhibitor solution that provides treatment for myeloproliferative neoplasms (MPNs) which are related to chronic cancers of the bone marrow, polycythemia vera (PV), and acute myeloid leukemia (AML). The company also offers treatments for conditions that involve Hemoglobinopathies and other solid tumors caused by LSD1 or lysine-specific demethylase 1. The company's revenue is generated by the sales of its therapeutic solutions to patients with conditions such as thrombocythemia, myelofibrosis, other myeloproliferative neoplasms, bone marrow diseases, and hematologic disorders. The company plans to widen the scope of its therapeutic solution by enrolling patients with an MPN known as essential thrombocythemia in Phase 2 clinical trials. As of July 2021, Imago BioSciences, Inc. also plans to become a publicly listed company under the ticker symbol IMGO on the Nasdaq.
Who invested in Imago BioSciences
18 investors across 3 rounds
See all investors in Imago BioSciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Imago BioSciences
Who invested in Imago BioSciences?
Imago BioSciences has 18 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Imago BioSciences raised?
Imago BioSciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Imago BioSciences last raise money?
Imago BioSciences's most recent round on record is a Series C, in Nov 2020.
What does Imago BioSciences do?
Founded in 2012 and based in California, US, Imago BioSciences, Inc.
Where is Imago BioSciences headquartered?
Imago BioSciences is headquartered in San Francisco, US.
Which VCs invest in companies like Imago BioSciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Imago BioSciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Imago BioSciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.